July 04, 2024 article Open access Multiple myeloma: signaling pathways and targeted therapy Molecular Biomedicine DOI: 10.1186/s43556-024-00188-w Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 1 stored of 86 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Antibody avidity meets multiple myeloma 2024 Nature Cancer article Medicine Multiple Myeloma Research and Treatments Open access 0 citations 1 result References 3 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma 2023 New England Journal of Medicine article Medicine Multiple Myeloma Research and Treatments Open access cited by 1 patent 588 citations Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial 2021 The Lancet Oncology article Medicine Multiple Myeloma Research and Treatments Open access 376 citations Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain 2023 Journal of Hematology & Oncology article Medicine CAR-T cell therapy research Open access 11 citations 3 results